We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+4.44%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.49B
AUM Growth
+$60.2M
Cap. Flow
+$11.8M
Cap. Flow %
0.79%
Top 10 Hldgs %
38.05%
Holding
161
New
4
Increased
69
Reduced
20
Closed
5

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$10.9M
2
KLAC icon
KLA
KLAC
+$3.03M
3
WDC icon
Western Digital
WDC
+$2.92M
4
CHKP icon
Check Point Software Technologies
CHKP
+$2.49M
5
AAPL icon
Apple
AAPL
+$1.63M

Top Sells

Rank Stock Value
1
CSRA
CSRA Inc.
CSRA
+$13.6M
2
JPM icon
JPMorgan Chase
JPM
+$9.98M
3
AZN icon
AstraZeneca
AZN
+$1.22M
4
BDX icon
Becton Dickinson
BDX
+$1.19M
5
GLW icon
Corning
GLW
+$1.13M

Sector Composition

Rank Sector Weight
1 Technology 36.4%
2 Financials 16.86%
3 Communication Services 15.69%
4 Healthcare 12.35%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CAH icon
76
Cardinal Health
CAH
$53.4B
$2.96M 0.2%
60,550
+7,300
+14% +$414K
TECK icon
77
Teck Resources
TECK
$29.5B
$2.96M 0.2%
116,174
+26,360
+29% +$706K
IBOC icon
78
International Bancshares
IBOC
$4.77B
$2.93M 0.2%
68,428
+198
+0.3% +$8.31K
UNH icon
79
UnitedHealth
UNH
$382B
$2.86M 0.19%
11,650
-190
-2% -$45.6K
DGX icon
80
Quest Diagnostics
DGX
$25.1B
$2.72M 0.18%
24,700
-700
-3% -$72.9K
JNJ icon
81
Johnson & Johnson
JNJ
$635B
$2.61M 0.17%
21,490
– –
CRL icon
82
Charles River Laboratories
CRL
$10.9B
$2.6M 0.17%
23,130
– –
CI icon
83
Cigna
CI
$76.6B
$2.38M 0.16%
14,000
– –
DXC icon
84
DXC Technology
DXC
$1.63B
$2.06M 0.14%
25,600
-3,994
-13% -$343K
FFIV icon
85
F5
FFIV
$22.1B
$2.04M 0.14%
11,805
– –
ILMN icon
86
Illumina
ILMN
$29.4B
$2.01M 0.13%
7,402
– –
BIDU icon
87
Baidu
BIDU
$35.8B
$1.98M 0.13%
8,150
– –
ACH
88
Accendra Health
ACH
$240M
$1.89M 0.13%
113,100
– –
CTXS
89
DELISTED
Citrix Systems Inc
CTXS
$1.69M 0.11%
16,090
– –
SIMO icon
90
Silicon Motion
SIMO
$9.19B
$1.64M 0.11%
31,000
– –
GSBC icon
91
Great Southern Bancorp
GSBC
$863M
$1.6M 0.11%
28,010
– –
LRCX icon
92
Lam Research
LRCX
$382B
$1.6M 0.11%
92,550
– –
ENDP
93
DELISTED
Endo International plc
ENDP
$1.6M 0.11%
169,570
– –
CELG
94
DELISTED
Celgene Corp
CELG
$1.49M 0.1%
18,700
– –
DELL icon
95
Dell
DELL
$283B
$1.47M 0.1%
62,064
– –
CRUS icon
96
Cirrus Logic
CRUS
$6.74B
$1.47M 0.1%
38,215
– –
FTNT icon
97
Fortinet
FTNT
$112B
$1.39M 0.09%
111,025
-17,675
-14% -$209K
AVTA
98
DELISTED
Avantax, Inc. Common Stock
AVTA
$1.32M 0.09%
35,780
-13,570
-27% -$438K
V icon
99
Visa
V
$677B
$1.26M 0.08%
9,502
– –
VTRS icon
100
Viatris
VTRS
$20.1B
$1.26M 0.08%
34,800
+9,400
+37% +$369K
2 3
4
5 6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Oak Associates held 161 positions worth $1.49B, up 4.2% from $1.43B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Oak Associates's Q2 2018 filing shows 4 new, 69 increased, 20 reduced and 5 closed positions. Its largest new stake was Perspecta Inc. Common Stock: 28,830 shares worth $592K. The largest sale was CSRA Inc., an estimated $13.6M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 36% a quarter earlier, followed by Financials and Communication Services.

  • Oak Associates's largest Q2 2018 buy was Perspecta Inc. Common Stock: 28,830 shares worth $592K.
  • Oak Associates added most to Novartis in Q2 2018, an estimated $10.9M increase.
  • Oak Associates's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $9.98M.
  • Oak Associates fully exited CSRA Inc. in Q2 2018, selling an estimated $13.6M.
  • Oak Associates's ten largest holdings make up 38% of its $1.49B portfolio in Q2 2018.
  • Oak Associates opened 4 new positions and closed 5 in Q2 2018.
  • Oak Associates's portfolio value rose 4.2% quarter-over-quarter to $1.49B.

Based on Oak Associates's 13F filing for Q2 2018, filed 14 Aug 2018.